Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.98K Buy
38
+1
+3% +$105 ﹤0.01% 2053
2024
Q4
$4.02K Hold
37
﹤0.01% 2083
2024
Q3
$3.95K Sell
37
-25
-40% -$2.53K ﹤0.01% 2112
2024
Q2
$6.14K Sell
62
-22
-26% -$2.21K ﹤0.01% 1891
2024
Q1
$7.77K Buy
84
+76
+950% +$6.12K ﹤0.01% 1693
2023
Q4
$604 Sell
8
-8
-50% -$520 ﹤0.01% 2556
2023
Q3
$969 Hold
16
﹤0.01% 2366
2023
Q2
$1.15K Hold
16
﹤0.01% 2340
2023
Q1
$887 Sell
16
-4
-20% -$221 ﹤0.01% 2484
2022
Q4
$1.01K Buy
20
+10
+100% +$494 ﹤0.01% 2464
2022
Q3
$0 Hold
10
﹤0.01% 2763
2022
Q2
$0 Sell
10
-5
-33% -$248 ﹤0.01% 2616
2022
Q1
$1K Buy
+15
New +$839 ﹤0.01% 2261
2020
Q2
Sell
-18
Closed -$1K 1793
2020
Q1
$1K Buy
+18
New +$1.37K ﹤0.01% 1479

Other funds holding ITRI

Lindbrook Capital's ITRI Position: Q1 2025 in Review

Lindbrook Capital increased its Itron (ITRI) stake by 2.7% in Q1 2025, buying an estimated $105 and bringing the position to 38 shares worth $3.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Lindbrook Capital first reported a position in ITRI in Q1 2020 and has held it in 14 quarters since. The position peaked at $7.77K in Q1 2024. 426 funds tracked by Wall St. Rank hold ITRI as of Q1 2025.

  • Lindbrook Capital held 38 shares of Itron worth $3.98K as of Q1 2025.
  • Lindbrook Capital bought 1 Itron share in Q1 2025, an estimated $105.
  • Itron made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2053 holding.
  • Lindbrook Capital first reported a position in Itron in Q1 2020 and has held it in 14 quarters since.
  • Lindbrook Capital's Itron position peaked at $7.77K in Q1 2024.
  • 426 funds tracked by Wall St. Rank held Itron as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.